IGF1 and Alzheimer disease: To decipher the signaling pathway of IGF1 in AD, we constructed a PPI network and co-expression modules of DEGs interacting with low IGF1 expression, thus to illuminate the genome-level pathogenesis of IGF1 underlying AD onset.